![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Mondello, Patrizia; Tadros, Saber; Teater, Matt; Fontan, Lorena; Chang, Aaron Y.; Jain, Neeraj; Yang, Haopeng; Singh, Shailbala; Ying, Hsia-Yuan; Chu, Chi-Shuen; Ma, Man Chun John; Toska, Eneda; Alig, Stefan; Durant, Matthew; de Stanchina, Elisa; Ghosh, Sreejoyee; Mottok, Anja; Nastoupil, Loretta; Neelapu, Sattva S.; Weigert, Oliver; Inghirami, Giorgio; Baselga, Jose; Younes, Anas; Yee, Cassian; Dogan, Ahmet; Scheinberg, David A.; Roeder, Robert G.; Melnick, Ari M. und Green, Michael R.
(2020):
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
In: Cancer Discovery, Bd. 10, Nr. 3: S. 440-459
Rauert-Wunderlich, Hilka; Mottok, Anja; Scott, David W.; Rimsza, Lisa M.; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Hartmann, Sylvia; Thorns, Christoph; Rymkiewicz, Grzegorz; Holte, Harald; Dreyling, Martin; Hoster, Eva und Rosenwald, Andreas
(Februar 2019):
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
In: British Journal of Haematology, Bd. 184, Nr. 4
Silva, Anjali; Bassim, Sleiman; Sarkozy, Clémentine; Mottok, Anja; Lackraj, Tracy; Jurinovic, Vindi; Brodtkorb, Marianne; Lingjaerde, Ole Christian; Sehn, Laurie H.; Gascoyne, Randy D.; Weigert, Oliver; Steidl, Christian und Kridel, Robert
(2019):
Convergence of risk prediction models in follicular lymphoma.
In: Haematologica, Bd. 104, Nr. 6, e252-e255
Mottok, Anja; Jurinovic, Vindi; Farinha, Pedro; Rosenwald, Andreas; Leich, Ellen; Ott, German; Horn, Heike; Klapper, Wolfram; Boesl, Michael; Hiddemann, Wolfgang; Steidl, Christian; Connors, Joseph M.; Sehn, Laurie H.; Gascoyne, Randy D.; Hoster, Eva; Weigert, Oliver und Kridel, Robert
(Januar 2018):
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens.
In: Blood, Bd. 131, Nr. 2: S. 226-235